Epithelial to mesenchymal transition and breast cancer

被引:233
作者
Tomaskovic-Crook, Eva [1 ]
Thompson, Erik W. [2 ,3 ]
Thiery, Jean Paul [1 ]
机构
[1] Inst Mol & Cell Biol, Singapore 138673, Singapore
[2] St Vincents Inst Med Res, Melbourne, Vic 3065, Australia
[3] Univ Melbourne, Dept Surg, St Vincents Hosp, Melbourne, Vic 3065, Australia
来源
BREAST CANCER RESEARCH | 2009年 / 11卷 / 06期
关键词
CIRCULATING TUMOR-CELLS; BONE-MARROW MICROMETASTASIS; BASAL-LIKE PHENOTYPE; GENE-EXPRESSION; STEM-CELL; MAMMARY-TUMORS; METASTATIC-DISEASE; CLINICAL-RELEVANCE; HISTOLOGICAL GRADE; PROGNOSTIC-FACTOR;
D O I
10.1186/bcr2416
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Epithelial-mesenchymal plasticity in breast carcinoma encompasses the phenotypic spectrum whereby epithelial carcinoma cells within a primary tumor acquire mesenchymal features and re-epithelialize to form a cohesive secondary mass at a metastatic site. Such plasticity has implications in progression of breast carcinoma to metastasis, and will likely influence response to therapy. The transcriptional and epigenetic regulation of molecular and cellular processes that underlie breast cancer and result in characteristic changes in cell behavior can be monitored using an increasing array of marker proteins. Amongst these markers exists the potential for emergent prognostic, predictive and therapeutic targeting.
引用
收藏
页数:10
相关论文
共 88 条
[1]  
Ahmad A, 1998, AM J PATHOL, V152, P721
[2]   The transcription factor ZEB1 (δEF1) promotes tumour cell dedifferentiation by repressing master regulators of epithelial polarity [J].
Aigner, K. ;
Dampier, B. ;
Descovich, L. ;
Mikula, M. ;
Sultan, A. ;
Schreiber, M. ;
Mikulits, W. ;
Brabletz, T. ;
Strand, D. ;
Obrist, P. ;
Sommergruber, W. ;
Schweifer, N. ;
Wernitznig, A. ;
Beug, H. ;
Foisner, R. ;
Eger, A. .
ONCOGENE, 2007, 26 (49) :6979-6988
[3]   Stem cell and epithelial-mesenchymal transition markers are frequently overexpressed in circulating tumor cells of metastatic breast cancer patients [J].
Aktas, Bahriye ;
Tewes, Mitra ;
Fehm, Tanja ;
Hauch, Siegfried ;
Kimmig, Rainer ;
Kasimir-Bauer, Sabine .
BREAST CANCER RESEARCH, 2009, 11 (04)
[4]   Circulating tumor cells and bone marrow micrometastasis [J].
Alix-Panabieres, Catherine ;
Riethdorf, Sabine ;
Pantel, Klaus .
CLINICAL CANCER RESEARCH, 2008, 14 (16) :5013-5021
[5]   Rb depletion results in deregulation of E-cadherin and induction of cellular phenotypic changes that are characteristic of the epithelial-to-mesenchymal transition [J].
Arima, Yoshimi ;
Inoue, Yasumichi ;
Shibata, Tatsuhiro ;
Hayashi, Hidemi ;
Nagano, Osamu ;
Saya, Hideyuki ;
Taya, Yoichi .
CANCER RESEARCH, 2008, 68 (13) :5104-5112
[6]   Most early disseminated cancer cells detected in bone marrow of breast cancer patients have a putative breast cancer stem cell phenotype [J].
Balic, Marija ;
Lin, Henry ;
Young, Lillian ;
Hawes, Debra ;
Giuliano, Armando ;
McNamara, George ;
Datar, Ram H. ;
Cote, Richard J. .
CLINICAL CANCER RESEARCH, 2006, 12 (19) :5615-5621
[7]   Clinical utility of cytokeratins as tumor markers [J].
Barak, V ;
Goike, H ;
Panaretakis, KW ;
Einarsson, R .
CLINICAL BIOCHEMISTRY, 2004, 37 (07) :529-540
[8]   Beyond Trastuzumab: Overcoming Resistance to Targeted HER-2 Therapy in Breast Cancer [J].
Bedard, Philippe L. ;
de Azambuja, Evandro ;
Cardoso, Fatima .
CURRENT CANCER DRUG TARGETS, 2009, 9 (02) :148-162
[9]   Prognosis of women with stage IV breast cancer depends on detection of circulating tumor cells rather than disseminated tumor cells [J].
Bidard, F. -C. ;
Vincent-Salomon, A. ;
Sigal-Zafrani, B. ;
Dieras, V. ;
Mathiot, C. ;
Mignot, L. ;
Thiery, J. -P. ;
Sastre-Garau, X. ;
Pierga, J. -Y. .
ANNALS OF ONCOLOGY, 2008, 19 (03) :496-500
[10]   Disseminated tumor cells of breast cancer patients: A strong prognostic factor for distant and local relapse [J].
Bidard, Francois-Clement ;
Vincent-Salomon, Anne ;
Gomme, Stephanie ;
Nos, Claude ;
de Rycke, Yann ;
Thiery, Jean Paul ;
Sigal-Zafrani, Brigitte ;
Mignot, Laurent ;
Sastre-Garau, Xavier ;
Pierga, Jean-Yves .
CLINICAL CANCER RESEARCH, 2008, 14 (11) :3306-3311